Scientific Program

Wednesday, 7 May 2025
18:00-19:00 Welcome Reception and Networking
Exhibit and Poster Hall Open
Thursday, 8 May 2025
08:00-09:00 Congress Welcome and Invited Award Lectures
• Welcome from IAPRD President and Congress Leaders
• IAPRD Lifetime Achievement Award Lecture
• IAPRD Melvin Yahr Award Lecture
09:00-10:30 General Session 1: Pathophysiology of Parkinson’s and Related Disorders
Chair: Serge Przedborski (New York, USA)
Chair: Ryan Uitti (Jacksonville, USA)

Workshop 1: PRD Foundations – A Practical Approach to Diagnosing and Treating Parkinson’s Disease and Related Disorders

Part I: Hypokinetic Disorders
Chair: Vicki Shanker (New York, USA)

09:00-09:30 1a: Synuclein-based biomarkers: what they do and do not tell us
Andrew Siderowf (Philadelphia, USA)
1a: Diagnosis and diagnostic testing in Parkinson’s disease
Vicki Shanker (New York, USA)
09:30-10:00 1b: Are we forgetting tau as a biomarker?
Giorgia Melli (Lugano, Switzerland)
1b: PD treatment spectrum—from de novo to advanced
Matt Swan (New York, USA)
10:00-10:30 1c: Making sense of biomarkers and co-pathology
1c: Diagnostic and treatment pearls in atypical parkinsonism
Stephen Reich (Baltimore, USA)
10:30-11:00 Coffee Break (Exhibit and Poster Hall open)
11:00-12:30 Parallel Session 1: From Genetics to Targeted Therapy
Chair: Andreas Puschmann (Lund, Sweden)
Chair: Huifang Shang (Chengdu, China)
Parallel Session 2: Botulinum Neurotoxin Opportunities and Techniques
Chair: Mark Lew (Los Angeles, USA)
Chair: Steven Frucht (New York, USA)

Workshop 1: continued

Part II: Hyperkinetic Disorders
Chair: Alessandro Di Rocco (New York, USA)
Chair: Joohi Jimenez-Shahed (New York, USA)

11:00-11:30 1a: Genetic testing for parkinsonism
Roy Alcalay (New York, USA; Tel Aviv, Israel)
2a: Choosing specific botulinum toxins for selected indications
Barbara Karp (Bethesda, USA)
1d: Common pediatric movement disorders and the continuum to adulthood
Emmanuel Roze (Paris, France)
11:30-12:00 1b: Genetic testing for ataxia
Mario Cornejo Olivas (Lima, Peru)
2b: Botulinum toxin use in Parkinson’s disease
Anna Castagna (Milan, Italy)
1e: Dystonia classification, genetics, and treatment implications
Rachel Saunders-Pullman (New York, USA)
12:00-12:30 1c: Testing and care for Friedrich ataxia
2c: Botulinum neurotoxin use in task-specific dystonia
Steven Frucht (New York, USA)
1f: Phenomenology and treatment of hyperkinetic disorders
Andres Deik (Philadelphia, USA)
12:30-14:30

Lunch Break (Exhibit and Poster Hall open)

14:30-16:00 Parallel Session 3: It Takes a Village: Comprehensive Approach to Caring for Parkinson’s
Chair: Ryan Uitti (Jacksonville, USA)
Chair: Maja Trošt (Ljubljana, Slovenia)
Parallel Session 4: Paroxysmal and Episodic Movement Disorders
Chair: Pramod Pal (Bangalore, India)
Workshop 2: Deep Brain Stimulation Skills
14:30-15:00 3a: Multidisciplinary team care
4a: Neurophysiological and genetic evaluation
Roberto Erro (Salerno, Italy)
14:30-15:25 Part 1: Case-based selection and targeting
14:30-14:50 2a: DBS in Parkinson’s disease / essential tremor
Okeanis Vaou (San Antonio, USA)
14:50-15:10 2b: DBS in dystonia and other conditions
Rubens Cury (Sao Paolo, Brazil)
15:10-15:25 Questions / panel
15:25-15:40 Break
15:40-16:55 Part 2: Case-based programming
15:40-16:00 2c: Programming principles, patient assessment and remote programming
Leo Verhagen (Chicago, USA)
16:00-16:20 2d: Neurophysiology guided DBS programming
Maria Contarino (Leiden, Netherlands)
16:20-16:40 2e: Image-guided DBS programming
Jens Volkmann (Würzburg, Germany)
16:40-16:55 Questions / panel
17:00-18:30 Device Rotations: Hands-on session
Monica Volz (San Francisco, USA)
Drew Kern (Aurora, USA)
Joan Miravite (New York, USA)
Mitesh Lotia (Orlando, USA)
Britt Stone (Nashville, USA)
15:00-15:30 3b: Rehabilitation
Theresa Ellis (Boston, USA)
4b: Autoimmune underpinnings
Bettina Balint (Zurich, Switzerland)
15:30-16:00 3c: Palliative care and improving quality of life
4c: Treatment options
Hyder Jinnah (Atlanta, USA)
16:00-17:00 Coffee Break (Exhibit and Poster Hall open)
Coffee with the Professor
16:00-17:00 Guided Poster Tours
17:00-18:30 General Session 2: Driving Scientific Discovery With Bioinformatics, AI and Innovation

17:00-17:30 2a: Big data and the bioinformatics revolution in diagnostics and beyond
Michael Zech (Munich, Germany)
17:30-18:00 2b: Artificial intelligence and clinical discovery: predictive AI, modeling, clinical decision support and personalized medicine
Maria Chiara Malaguti (Trento, Italy)
18:00-18:30 2c: Generative AI and innovative monitoring of Parkinson’s and related disorders
18:45-22:00 Faculty Dinner
Friday, 9 May 2025
08:00-09:00

Exhibit and Poster Hall Open

IAPRD General Business Meeting
08:00-09:00 Guided Poster Tours
09:00-10:30 General Session 3: Novel and Translational Therapeutics for Parkinson’s and Related Disorders
Chair: Elena Moro (Grenoble, France)
09:00-09:30 3a: Novel cell therapies
Ryosuke Takahashi (Kyoto, Japan)
09:30-10:00 3b: Therapeutic strategies based on inflammation/immunotherapy
10:00-10:30 3c: Antidiabetic and other potential neurorestorative agents
10:30-11:00 Coffee Break
11:00-12:30 Parallel Session 5: Update on Neuromodulation for Hypo- and Hyperkinetic Disorders
Chair: Alfonso Fasano (Toronto, Canada)
Chair: Elena Moro (Grenoble, France)
Parallel Session 6: Defining and Treating Atypical Parkinsonism
Chair: Lawrence Honig (New York, USA)
Chair: Emelia Gatto (Buenos Aires, Argentina)
Workshop 3: Botulinum Toxin Injection Workshop
Chair: Alberto Albanese (MIlan, Italy)
Chair: David Simpson (New York, USA)
11:00-11:30 5a: MR- guided focused ultrasound
6a: Differentiating PSP, MSA, and corticobasal syndrome
Ai-Huey Tan (Kuala Lumpur, Malaysia)

3a: Clinical utility of botulinum neurotoxins
Alberto Albanese (Milan, Italy)

3b: Techniques for muscle localization
Katharine Alter (Bethesda, USA)

3c: Injection demonstration video cases
Jaroslaw Slawek (Gdansk, Poland)
David Simpson (New York, USA)

11:30-12:00 5b: Deep brain stimulation
6b: Therapeutic approaches
12:00-12:30 5c: Neuromodulatory neurostimulation (TMS, tDCS, TAS, TUS, TI)
Robert Chen (Toronto, Canada)
6c: Debate: Is neuropathology the gold standard for diagnosis? Yes/No
12:30-14:30

Lunch Break (Exhibit and Poster Hall Open)

14:30-16:00 Parallel Session 7: Management of Advanced Parkinson’s
Chair: Zoltan Mari (Las Vegas, USA)
Chair: Jinyoung Youn (Seoul, Korea)
Parallel Session 8: Management of the Hyperkinetic Movement Disorders
Chair: Karen Frei (Loma Linda, USA)
Chair: Anhar Hassan (Dublin, Ireland)
Workshop 4: Diagnostic Testing for Parkinson’s Disease and Parkinsonism
Chair: Marie Saint-Hilaire (Boston, USA)
Chair: Roy Alcalay (New York, USA; Tel Aviv, Israel)
14:30-15:00 7a: Defining advanced PD and treatment needs
Indu Subramanian (Los Angeles, USA)
8a: Tardive syndromes
Roongroj Bhidayasiri (Bangkok, Thailand)

4a: Utility and interpretation of skin biopsy testing for alpha-synuclein

4b: Differential diagnosis with CSF diagnosis markers

4c: Current and emerging imaging markers and techniques
Marina Picillo (Salerno, Italy)

4d: Neurophysiology
John Caviness (Phoenix, USA)

15:00-15:30 7b: Cognitive and psychiatric issues
8b: Huntington disease
Sarah Tabrizi (London, UK)
15:30-16:00 7c: Motor fluctuations
Rajesh Pahwa (Kansas City, USA)
8c: Myoclonus and Tics
Christos Ganos (Toronto, Canada)
16:00-17:00

Coffee Break (Exhibit and Poster Hall open)
Coffee with the Professor

16:00-17:00 Guided Poster Tours
17:00-18:30 General Session 4: Innovative Advances in Neuromodulation
Chair: Joohi Jimenez-Shahed (New York, USA)
Chair: Rubens Cury (Sao Paolo, Brazil)
17:00-17:30 4a: Closing the loop in DBS
Helen Bronte-Stewart (Stanford, USA)
17:30-18:00 4b: Connecting the dots: connectomic DBS
Andreas Horn (Boston, USA)
18:00-18:30 4c: Are we ready for automated DBS programming?
Svjetlana Miocinovic (Atlanta, USA)
Saturday, 10 May 2025
08:00-08:30 Morning Coffee
08:15-09:15 Guided Poster Tours
09:30-11:00 General Session 5: Grand Parade of Movement Disorders Video Session
Moderator/Master of Ceremonies: Hubert Fernandez (Cleveland, USA)
Discussant: Michael Zech (Munich, Germany)
Discussant: Ruth Walker (New York, USA)
Discussant: Pramod Pal (Bangalore, India)
Discussant: Bettina Balint (Zurich, Switzerland)
11:00-11:30

Best Papers in Parkinsonism and Related Disorders and Clinical Parkinsonism and Related Disorders
PRD: 11:00-11:20
CPRD: 11:20-11:30

11:30-12:20 IAPRD 2025 Congress Awards and Closing Ceremony